Evid Invest
Who owns IMCRWhat IMCR owns — n/a

Who owns Immunocore Holdings plc?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of IMCR from SEC Form 13F filings across 130 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-09-30 reporting period, 130 institutions disclosed 51.3M shares of Immunocore Holdings plc worth $1.55B — about 99.4% of shares outstanding; the largest disclosed holder is WELLINGTON MANAGEMENT GROUP LLP. Source: SEC Form 13F filings, parsed by EvidInvest.

130

13F holders

$1.55B

value, 2026 filers

99.4%

of shares outstanding (51.3M sh)

17

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of IMCR's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1WELLINGTON MANAGEMENT GROUP LLP5.7M$173.1M0.0%11.1%-0.1%
2RTW INVESTMENTS, LP4.9M$147.5M1.5%9.4%0.0%
3PRIMECAP MANAGEMENT CO/CA/3.6M$110.1M0.1%7.1%-0.1%
4TANG CAPITAL MANAGEMENT LLC2.9M$87.4M4.0%5.6%+8.9%
5Bellevue Group AG2.3M$68.6M1.4%4.4%-18.8%
6TWO SIGMA INVESTMENTS, LP2.0M$61.0M0.0%3.9%+22.2%
7ACADIAN ASSET MANAGEMENT LLC1.8M$55.2M0.1%3.5%+50.8%
8FMR LLC1.7M$52.6M0.0%3.4%-59.7%
9Caligan Partners LP1.7M$50.6M3.1%3.2%+21.1%
10Kynam Capital Management, LP1.4M$41.6M2.3%2.7%0.0%
11Point72 Asset Management, L.P.1.3M$38.1M0.0%2.4%+27.0%
12BVF INC/IL1.2M$37.3M1.2%2.4%-4.9%
13MPM BIOIMPACT LLCNEW1.2M$36.4M2.7%2.3%new
14ARMISTICE CAPITAL, LLC1.1M$34.4M0.4%2.2%-20.4%
15Trails Edge Capital Partners, LP1.1M$32.2M4.6%2.1%0.0%
16BlackRock, Inc.1.0M$31.7M0.0%2%+4.3%
17FARALLON CAPITAL MANAGEMENT, L.L.C.NEW928,000$28.1M0.1%1.8%new
18BRAIDWELL LP906,115$27.4M1.1%1.8%+73.8%
19Janus Henderson Group Ltd.NEW868,112$26.3M0.0%1.7%new
20Vestal Point Capital, LP850,000$25.7M0.7%1.6%-52.8%
21MILLENNIUM MANAGEMENT LLC839,258$25.4M0.0%1.6%-47.4%
22Frazier Life Sciences Management, L.P.829,752$25.1M0.6%1.6%+71.2%
23MARSHALL WACE, LLP614,728$18.6M0.0%1.2%+4.0%
24D. E. Shaw & Co., Inc.561,415$17.0M0.0%1.1%+38.6%
25Hudson Bay Capital Management LP535,000$16.2M0.0%1%-9.3%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.